AIM

Allenby Capital reports AIM Activity through end April 2022 – Markets quiet but not shut

After AIM’s biggest year for fundraises since 2007, 2021 was always going to be a hard act to follow. 2022 has so far been quiet but the market isn’t shut with funds still being raised for attractive opportunities. £99.7m of new money was raised on AIM through to the end of April 2022 across 11 new joiners to the market, this compares to the £598m raised during the comparable period in 2021 from 21 new joiners. The secondary fundraise market has ...
Post Date: June 19, 2022 Read more

AIM market statistics

by Cliff Weight, Sharesoc Director. Allenby have just published this very informative review of AIM: http://www.allenbycapital.com/research_1214_2120899233.pdf which contains many interesting statistics. The AIM market is at the same level it was 20 years ago, but the journey between has been very volatile. However the last 5 years, with the exception of last March's blip, has been most encouraging. It may be that fewer scandals than in the past have occurred. However ShareSoc is still campaigning hard to get better regulation of the AIM ...
Post Date: May 13, 2021 Read more

Continued strong fundraising activity on AIM

Allenby Capital, whose CEO Nick Naylor spoke at ShareSoc's Investing Masterclass on Remuneration, have just issued their quarterly update which shows the way the AIM market continues to help companies requiring capital. AIM is playing an important role in these difficult Covid times, writes ShareSoc Director Cliff Weight. Key points in the report: AIM continued its strong fundraising performance in Q3 2020. By the end of September, the total funds raised year to date of £4,085m had already surpassed the £3,997m raised ...
Post Date: October 31, 2020 Read more

Laggard Hugely Disappointing That ImmuPharma Excludes Individuals From Placing

I have been an investor, supporter and follower of ImmuPharma. So I was appalled to read that ImmuPharma (LSE:IMM) has raised £6.5 million, before expenses, via an oversubscribed placing of 59,090,909 new ordinary shares at a price of 11p per share. There was no Primary Bid offer and no notification to investors who hold their shares via nominee of this placing nor any invitation for them to share in the spoils. The placing was at 11p and the share price this morning ...
Post Date: September 3, 2020 Read more

More on Placings – AVACTA

AVACTA (AVCT) has seen its share price rise from 100p on May 13 to 200p and then decline to 140p. I feel sorry for those investors who bought at around 200p. The sharp decline in the share price (20p on Tuesday and 20p on Wednesday) could be evidence that this deal has leaked. Source: Interactive Investor The £25m placing price is 120p, so the fact that the share price is staying stable today at 140p (at 09.48 as I write) suggests, in my  opinion, ...
Post Date: June 4, 2020 Read more

How important is the Individual Shareholder to UK PLC in the current climate?

On Thursday 7 May 2020 The LSE and Primary Bid ran a webinar on How important is the Individual to UK PLC in the current climate? There was an impressive panel made up of: Gavin Oldham, Chairman - Share Centre Richard Wilson, CEO - interactive investor Angela Knight CBE Andy Edmond, CEO, Equity Development Marcus Stuttard, Head of UK Primary Markets and AIM - London Stock Exchange plc The Chairman was  James Deal, COO - PrimaryBid The topics  discussed were: The daily trading ...
Post Date: May 10, 2020 Read more

Allenby Capital – AIM Market Update – Q4 2019

Allenby have posted a useful note on the state of Aim with lots of data, click here to Download note Key points: December bounce but 2019 remained a down...
Post Date: January 29, 2020 Read more

ShareSoc – LSE AIM meeting

On 26 Sept 2019, four ShareSoc Directors (Northway, Bentley, Spencer Phillips and Weight) met Marcus Stuttard and 4 other senior executives of LSE AIM to discuss AIM regulation. This was a wide ranging meeting which both sides agreed was very useful. We updated the LSE on the UKSA-ShareSoc merger and the ShareSoc-SIGnet merger; then proceeded to discuss the Law Commission call for evidence re intermediated securities; Auditors, ARGA, Kingman, Brydon, CMA, etc.; Change of Auditors and the need for clear RNS about ...
Post Date: October 29, 2019 Read more

Telit: Warning Signs in the Remuneration Report

Today the CEO, Cats, has left Telit. Trust between shareholders and the company is fundamental. Cats lied to the company and the company failed to disclose relevant information to its shareholders. Cats was paid $3.37 million in 2016 made up of $1.63m salary and bonus of $1.74m. ShareSoc remuneration guidelines suggest £300k to £500k as a guideline for a company of this size c £250 million turnover. Cats owned 16 million shares and also has share options. So, such a large pay package ...
Post Date: August 14, 2017 Read more

United Cacao – the Perils of AIM, and Fyffes

The Daily Telegraph ran a lengthy article yesterday covering the story of AIM listed United Cacao Ltd SEZC (CHOC) under the headline – “a bitter warning of the perils...
Post Date: February 21, 2017 Read more
Skip to toolbar